Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Bayer AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bayer AG, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Bayer AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bayer AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Bayer AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Bayer AG, Medical Equipment, Deal Details 13
Private Equity 13
Bayer to Raise USD3.69 Billion in Private Placement of Shares 13
Partnerships 15
Bayer Enters into Licensing Agreement with DelSiTech 15
ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology 16
TissUse Enters into Co-development Agreement with Bayer 17
Icagen Enters into Agreement with Bayer 18
Bayer Enters into Co-Development Agreement with Leica Biosystems 19
T2 Biosystems Enters into R&D Agreement with Bayer 20
Genedata Enters into Co-Development Agreement with Bayer Pharma 21
Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 22
Ventana Extends Co-Development Agreement With Bayer Pharma 23
Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device 24
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 25
Equity Offering 26
Bayer Plans to Raise USD7 Billion in Rights Offering of Shares 26
Debt Offering 27
Bayer to Raise USD1.25 Billion in Private Placement of 3.5% Bonds Due 2021 27
Bayer to Raise USD2.5 Billion in Private Placement of 4.25% Bonds Due 2025 28
Bayer to Raise USD1.25 Billion in Private Placement of Bonds Due 2023 29
Bayer to Raise USD870 Million in Private Placement of Bonds Due 2022 30
Bayer to Raise USD1 Billion in Private Placement of 4.625% Bonds Due 2038 31
Bayer to Raise USD2.25 Billion in Private Placement of 3.875% Bonds Due 2023 32
Bayer to Raise USD2 Billion in Private Placement of 4.875% Bonds Due 2048 33
Bayer to Raise USD1.25 Billion in Private Placement of Bonds Due 2021 34
Bayer to Raise USD3.5 Billion in Private Placement of 4.375% Bonds Due 2028 35
Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 36
Bayer Raises USD1.4 Billion in Public Offering of 2.375% Hybrid Bonds Due 2075 37
Bayer Prices 1.25% Bonds Due 2023 for USD623.5 Million 38
Bayer Raises USD2.38 Billion in Public Offering of 3% Bonds Due 2075 39
Bayer Raises USD2 Billion in Public Offering of 3.75% Bonds Due 2074 41
Bayer Raises USD677.3 Million in Public Offering of Notes Due 2016 43
Bayer Raises USD1.02 Billion in Public Offering of 1.125% Notes Due 2018 44
Bayer Raises USD1.02 Billion in Public Offering of 1.875% Bonds Due 2021 45
Bayer Completes Public Offering Of Notes Due 2019 For US$102 Million 46
Bayer Completes Public Offering Of Notes Due 2016 For US$259 Million 47
Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million 48
Asset Transactions 49
Bayer May Sell Radiology Business 49
Panasonic Healthcare Acquires Diabetes Care Business from Bayer for USD1.15 Billion 50
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 51
Polymer Technology Systems Acquires A1CNow From Bayer Diabetes Care 52
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 53
Acquisition 54
Bayer May Acquire Sirtex Medical 54
Bayer Completes Acquisition Of 96.4% Stake In Conceptus For US$1.1 Billion 55
Bayer AG – Key Competitors 57
Bayer AG – Key Employees 58
Bayer AG – Locations And Subsidiaries 59
Head Office 59
Other Locations & Subsidiaries 59
Joint Venture 68
Recent Developments 69
Strategy And Business Planning 69
Mar 06, 2018: Travelers Partners with Cedars-Sinai, Samsung Electronics America, Bayer and appliedVR to Test Digital Tools in Treatment of Acute Orthopaedic Injuries 69
Financial Announcements 70
May 03, 2018: Bayer: Operational business held back by currency effects – Major progress with Monsanto acquisition 70
Oct 26, 2017: Bayer: Sales and earnings increased 74
Apr 27, 2017: Strong start to the year for Bayer 79
Corporate Communications 82
Sep 27, 2018: Bayer appoints Sebastian Guth to lead Pharmaceuticals business in the Americas 82
Sep 13, 2018: Bayer appointed Stefan Oelrich to Board of Management 83
May 07, 2018: Bayer announces Executive Leadership Team for new Crop Science division 85
Nov 15, 2017: Heiko Schipper to join Bayer Board of Management and head Consumer Health Division 87
Nov 15, 2017: Heiko Schipper is the new CEO and Head of the Consumer Health Division at Bayer 88
Oct 19, 2017: Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications 89
Sep 22, 2017: Bayer Appoints Dr. Sharon James Head of Global Innovation & Development for Consumer Health 90
Sep 12, 2017: Wolfgang Nickl to be new Chief Financial Officer at Bayer 91
Sep 07, 2017: Bayer again listed in the Dow Jones Sustainability World Index 92
Jun 05, 2017: Bayer Expands Oncology Organization with Two New Leadership Team Appointments 93
May 02, 2017: Bayer Appoints Bhavesh Ashar to Lead U.S. Oncology Business 94
Apr 27, 2017: Supervisory Board of Bayer extends service contract of CFO Johannes Dietsch to the end of May 2018 95
Jan 17, 2017: Dr. Carsten Brunn to Lead Bayer’s Pharmaceuticals Business in the Americas Region 96
Legal and Regulatory 97
Aug 22, 2017: Bayer will continue to work constructively with the European Commission 97
Government and Public Interest 98
Mar 28, 2018: Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives 98
Feb 22, 2017: Another record year for Bayer – good progress with the acquisition of Monsanto 99
Product News 103
Dec 04, 2017: NUST MISIS Students Develop an App for Patients with Bronchiectasis 103
Other Significant Developments 104
Mar 27, 2018: Bayer partners with Plug and Play To Address the Rapid Changes in Healthcare 104
Appendix 105
Methodology 105
About GlobalData 105
Contact Us 105
Disclaimer 105
Bayer AG, Medical Equipment, Key Facts, 2017 2
Bayer AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bayer AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bayer AG, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Bayer AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bayer AG, Deals By Market, 2012 to YTD 2018 10
Bayer AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Bayer to Raise USD3.69 Billion in Private Placement of Shares 13
Bayer Enters into Licensing Agreement with DelSiTech 15
ChromoTek Enters Into Licensing Agreement With Bayer For Cell Cycle Chromobody Technology 16
TissUse Enters into Co-development Agreement with Bayer 17
Icagen Enters into Agreement with Bayer 18
Bayer Enters into Co-Development Agreement with Leica Biosystems 19
T2 Biosystems Enters into R&D Agreement with Bayer 20
Genedata Enters into Co-Development Agreement with Bayer Pharma 21
Orion Enters into Agreement with Bayer for Prostate Cancer Treatment 22
Ventana Extends Co-Development Agreement With Bayer Pharma 23
Bayer Yakuhin Enters Into Distribution Agreement With Femasys For FemVue Saline-Air Device 24
Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma 25
Bayer Plans to Raise USD7 Billion in Rights Offering of Shares 26
Bayer to Raise USD1.25 Billion in Private Placement of 3.5% Bonds Due 2021 27
Bayer to Raise USD2.5 Billion in Private Placement of 4.25% Bonds Due 2025 28
Bayer to Raise USD1.25 Billion in Private Placement of Bonds Due 2023 29
Bayer to Raise USD870 Million in Private Placement of Bonds Due 2022 30
Bayer to Raise USD1 Billion in Private Placement of 4.625% Bonds Due 2038 31
Bayer to Raise USD2.25 Billion in Private Placement of 3.875% Bonds Due 2023 32
Bayer to Raise USD2 Billion in Private Placement of 4.875% Bonds Due 2048 33
Bayer to Raise USD1.25 Billion in Private Placement of Bonds Due 2021 34
Bayer to Raise USD3.5 Billion in Private Placement of 4.375% Bonds Due 2028 35
Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 36
Bayer Raises USD1.4 Billion in Public Offering of 2.375% Hybrid Bonds Due 2075 37
Bayer Prices 1.25% Bonds Due 2023 for USD623.5 Million 38
Bayer Raises USD2.38 Billion in Public Offering of 3% Bonds Due 2075 39
Bayer Raises USD2 Billion in Public Offering of 3.75% Bonds Due 2074 41
Bayer Raises USD677.3 Million in Public Offering of Notes Due 2016 43
Bayer Raises USD1.02 Billion in Public Offering of 1.125% Notes Due 2018 44
Bayer Raises USD1.02 Billion in Public Offering of 1.875% Bonds Due 2021 45
Bayer Completes Public Offering Of Notes Due 2019 For US$102 Million 46
Bayer Completes Public Offering Of Notes Due 2016 For US$259 Million 47
Bayer Holding Completes Public Offering Of 0.82% Corporate Bonds Due 2017 For US$363 Million 48
Bayer May Sell Radiology Business 49
Panasonic Healthcare Acquires Diabetes Care Business from Bayer for USD1.15 Billion 50
Boston Scientific Acquires Vascular Catheter Business of Bayer for USD414 Million 51
Polymer Technology Systems Acquires A1CNow From Bayer Diabetes Care 52
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 53
Bayer May Acquire Sirtex Medical 54
Bayer Completes Acquisition Of 96.4% Stake In Conceptus For US$1.1 Billion 55
Bayer AG, Key Competitors 57
Bayer AG, Key Employees 58
Bayer AG, Subsidiaries 59
Bayer AG, Joint Venture 68
List of Figures
Bayer AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bayer AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bayer AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bayer AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bayer AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Bayer AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Bayer AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Bayer AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 10
